Company Overview
American HealthCare Capital is pleased to exclusively introduce an Orthotics & Prosthetics (O&P) Company for sale in the Midwest. This multi-location Prosthetics and Orthotics company provides comprehensive, custom O&P care for patients with custom orthoses, upper and lower extremity prostheses, and utilizes the most advanced technology for its products and services. Its in-house fabrication lab has state-of-the-art scanning and CAD equipment for fabrication of prostheses and orthoses for upper and lower extremities, including microprocessor-controlled prosthetics, bionic, and myoelectric limbs.
This premier company has generated revenue growth of 13.9% Compounded Annual Growth Rates (CAGR) over the past 4 years and is a market leader. It dominates its region with high-quality practitioners and custom services restoring mobility, function, and improving its patients’ lives every day.
Differentiators and Core Competencies
- High revenue growth of 13.9% Compound Annual Growth Rate (CAGR) over 4 years
- Strong increasing margins of Gross Profit of 68% and Adjusted EBITDA of 19%
- All ABC Accredited Facilities
- Certified CPOs (Certified Prosthetist Orthotist), CP/LP (Licensed Prosthetist), and LO (Licensed Orthotist)
- Complete adult custom orthotic and prosthetic services for upper and lower extremities
- Complete pediatric custom orthotic and prosthetic services
- In-House Fabrication Lab with state-of-the-art technology fully staffed
- Dedicated in-house CPO compliance officer
Product Mix
The Company’s product mix is 68% Prosthetics and 32% Orthotics. The Company’s payer mix consists of 34% Medicare, 33% Commercial Insurance, 12% VA and Nursing Homes, 10% Workers Comp, 10% Medicaid, and 1% Self-pay
Financial Overview
The Company’s revenues over the 4 years from 2022 to 2025 (pro forma) have grown at a compounded annual growth rate (CAGR) of 13.9%, with an increasing Gross Profit that has gone from 61% to 68% and an Adjusted EBITDA of 19%.
Asking Price
The asking price for this multi-location prosthetics and orthotics company is $14.5 million, plus the possibility of an earn-out going forward. This does not include cash, receivables, or working capital.
